Safety, Tolerability and Pharmacokinetics of 0.5% and 2.5% Cis-UCA Eye Drops in Adult Healthy Volunteers (Phase I)
Status:
Completed
Trial end date:
2012-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this two-part study is to evaluate safety, tolerability and pharmacokinetics
of 0.5% and 2.5% cis-UCA eye drops in comparison to placebo in adult healthy volunteers.